Association of Changes in Effusion-Synovitis With Progression of Cartilage Damage Over Eighteen Months in Patients With Osteoarthritis and Meniscal Tear.


Journal

Arthritis & rheumatology (Hoboken, N.J.)
ISSN: 2326-5205
Titre abrégé: Arthritis Rheumatol
Pays: United States
ID NLM: 101623795

Informations de publication

Date de publication:
01 2019
Historique:
received: 14 03 2018
accepted: 05 07 2018
pubmed: 23 8 2018
medline: 2 11 2019
entrez: 23 8 2018
Statut: ppublish

Résumé

Synovitis is a feature of knee osteoarthritis (OA) and meniscal tear and has been associated with articular cartilage damage. This study was undertaken to examine the associations of baseline effusion-synovitis and changes in effusion-synovitis with changes in cartilage damage in a cohort with OA and meniscal tear. We analyzed data from the Meniscal Tear in Osteoarthritis Research (MeTeOR) trial of surgery versus physical therapy for treatment of meniscal tear. We performed semiquantitative grading of effusion-synovitis and cartilage damage on magnetic resonance imaging, and dichotomized effusion-synovitis as none/small (minimal) and medium/large (extensive). We assessed the association of baseline effusion-synovitis and changes in effusion-synovitis with changes in cartilage damage size and depth over 18 months, using Poisson regression models. Analyses were adjusted for patient demographic characteristics, treatment, and baseline cartilage damage. We analyzed 221 participants. Over 18 months, effusion-synovitis was persistently minimal in 45.3% and persistently extensive in 21.3% of the patients. The remaining 33.5% of the patients had minimal synovitis on one occasion and extensive synovitis on the other. In adjusted analyses, patients with extensive effusion-synovitis at baseline had a relative risk (RR) of progression of cartilage damage depth of 1.7 (95% confidence interval [95% CI] 1.0-2.7). Compared to those with persistently minimal effusion-synovitis, those with persistently extensive effusion-synovitis had a significantly increased risk of progression of cartilage damage depth (RR 2.0 [95% CI 1.1-3.4]). Our findings indicate that the presence of extensive effusion-synovitis is associated with subsequent progression of cartilage damage over 18 months. The persistence of extensive effusion-synovitis over time is associated with the greatest risk of concurrent cartilage damage progression.

Identifiants

pubmed: 30133187
doi: 10.1002/art.40660
pmc: PMC6310094
mid: NIHMS980548
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

73-81

Subventions

Organisme : NIAMS NIH HHS
ID : K24 AR057827
Pays : United States
Organisme : NIAMS NIH HHS
ID : P60 AR047782
Pays : United States
Organisme : NIAMS NIH HHS
ID : T32 AR055885
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR055557
Pays : United States

Investigateurs

Robert H Brophy (RH)
Bruce A Levy (BA)
Robert G Marx (RG)
Mathew Matava (M)
Clare Safran-Norton (C)
Kurt P Spindler (KP)
Michael Stuart (M)
Diane L Dahm (DL)
Rick Wright (R)

Informations de copyright

© 2018, American College of Rheumatology.

Références

Osteoarthritis Cartilage. 2016 Mar;24(3):458-64
pubmed: 26432512
Contemp Clin Trials. 2012 Nov;33(6):1189-96
pubmed: 22968127
Arthritis Rheum. 2011 Feb;63(2):391-400
pubmed: 21279996
Osteoarthritis Cartilage. 2017 Feb;25(2):267-271
pubmed: 27697506
J Rheumatol. 2014 Mar;41(3):501-8
pubmed: 24429179
Radiology. 2009 Sep;252(3):772-80
pubmed: 19635831
Ann Rheum Dis. 2016 Mar;75(3):519-25
pubmed: 25550336
Arthritis Rheumatol. 2016 Apr;68(4):837-44
pubmed: 26636246
Osteoarthritis Cartilage. 2009 Jun;17(6):748-53
pubmed: 19008123
Eur J Radiol. 2011 Nov;80(2):e126-31
pubmed: 20833493
N Engl J Med. 2013 May 2;368(18):1675-84
pubmed: 23506518
Am J Epidemiol. 2003 May 15;157(10):940-3
pubmed: 12746247
J Orthop Sports Phys Ther. 1998 Aug;28(2):88-96
pubmed: 9699158
BMC Musculoskelet Disord. 2016 Nov 10;17(1):466
pubmed: 27832771
Ther Adv Musculoskelet Dis. 2013 Apr;5(2):77-94
pubmed: 23641259
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
Arthritis Care Res (Hoboken). 2017 Sep;69(9):1340-1348
pubmed: 27998036
Osteoarthritis Cartilage. 2011 Aug;19(8):990-1002
pubmed: 21645627
Arthritis Rheumatol. 2016 Mar;68(3):654-61
pubmed: 26554395
J Bone Joint Surg Am. 2003 Jan;85(1):4-9
pubmed: 12533565
Arthritis Rheumatol. 2016 Oct;68(10):2422-31
pubmed: 27111771
Semin Arthritis Rheum. 2013 Jun;42(6):573-81
pubmed: 23270763
Nat Rev Rheumatol. 2010 Nov;6(11):625-35
pubmed: 20924410

Auteurs

Lindsey A MacFarlane (LA)

Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Heidi Yang (H)

Brigham and Women's Hospital, Boston, Massachusetts.

Jamie E Collins (JE)

Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Mohamed Jarraya (M)

Boston University School of Medicine, Boston, Massachusetts.

Ali Guermazi (A)

Boston University School of Medicine, Boston, Massachusetts.

Lisa A Mandl (LA)

Hospital for Special Surgery and Weill Cornell Medicine, New York, New York.

Scott D Martin (SD)

Massachusetts General Hospital, Boston.

John Wright (J)

Johnson& Johnson, Raynham, Massachusetts.

Elena Losina (E)

Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Jeffrey N Katz (JN)

Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH